(Q34240879)

31 July 2017

1 reference

title

Lipids and atherosclerosis: clinical management of hypercholesterolaemia (English)

1 reference

31 July 2017

0 references

1 reference

Chin-Dusting JP

1

1 reference

31 July 2017

Shaw JA

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

419-430

1 reference

The relationship between coronary artery lesions and myocardial infarcts: ulceration of atherosclerotic plaques precipitating coronary thrombosis

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

Hypolipidemic effects in dogs of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

Lipids and the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

Comparison of intestinal absorption of cholesterol with different plant sterols in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

Pravastatin Therapy and the Risk of Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2.3.419

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.29.1346

Identifiers

DOI

10.1517/14656566.2.3.419

1 reference

31 July 2017

1 reference